Skip to search formSkip to main contentSkip to account menu

Piracetam

Known as: Pyramem, Piracetam [Chemical/Ingredient], Pyracetam 
A compound suggested to be both a nootropic and a neuroprotective agent.
National Institutes of Health

Related topics

Related topics

28 relations

Narrower (15)

2-thioxo-1-pyrrolidineacetamide4-phenylpiracetamGeramLevetiracetam

Broader (6)

AntiemeticsCentral Nervous System StimulantsNeuroprotective AgentsNootropic Agents
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Piracetam and Piracetam-Like Drugs
There is an increasing interest in nootropic drugs for the treatment of CNS disorders. Since the last meta-analysis of the… 
Review
2010
Review
2010
Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects
As a fully differentiated organ, our brain is very sensitive to cumulative oxidative damage of proteins, lipids, and DNA… 
Review
2006
Review
2006
Pharmaceutical co-crystals.
Crystal engineering has evolved in such a manner that it is now synonymous with the paradigm of supramolecular synthesis, that is… 
Review
2005
Review
2005
Piracetam: a review of pharmacological properties and clinical uses.
Piracetam, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), has a variety of physiological effects that may… 
Highly Cited
2002
Highly Cited
2002
Clinical Efficacy of Piracetam in Cognitive Impairment: A Meta-Analysis
A meta-analysis has been performed including nineteen double blind, placebo controlled studies with piracetam in patients… 
Highly Cited
2000
Highly Cited
2000
Piracetam Improves Activated Blood Flow and Facilitates Rehabilitation of Poststroke Aphasic Patients
Background and Purpose In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves… 
Highly Cited
1998
Highly Cited
1998
Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
We have previously shown that the novel anticonvulsant levetiracetam exerts potent anticonvulsant activity against both focal and… 
Highly Cited
1995
Highly Cited
1995
The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.
Highly Cited
1995
Highly Cited
1995
Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
Review
1994
Review
1994
Piracetam and other structurally related nootropics
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)